iTeos Therapeutics leaps as set to join S&P SmallCap index

iTeos Therapeutics

03/01/2022 13:49

** iTeos Therapeutics Inc  ITOS.O  shares up 10.1% premarket
at $51.25, on track to open at record high, as co poised to join
S&P SmallCap 600 index  .SPCY  this week
    ** Cancer drug developer to replace Magellan Health Inc
 MGLN.O  effective Weds, Jan 5  urn:newsml:reuters.com:*:nPnnbsYSa
    ** ITOS shares surged 72% in Q4 2021 and have ~$1.6 bln
market cap, per Refinitiv data. Stock set record high close of
$47.86 on Dec 28
    ** All 5 analysts covering ITOS recommend buying the stock
and their median PT is $52 - Refinitiv
    ** Centene Corp  CNC.N  acquiring Magellan in $2.2 bln deal
announced a year ago  urn:newsml:reuters.com:*:nPnnbsYSa

 (Lance Tupper is a Reuters market analyst. The views expressed
are his own)
 ((lance.tupper@thomsonreuters.com
lance.tupper@tr.com 1-332-219-1430))